Romano Roberta, Calcagnile Matteo, Margiotta Azzurra, Franci Lorenzo, Chiariello Mario, Alifano Pietro, Bucci Cecilia
Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, 73100 Lecce, Italy.
Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), 53100 Siena, Italy.
Cancers (Basel). 2021 May 6;13(9):2220. doi: 10.3390/cancers13092220.
RAB7A is a small GTPase that controls the late endocytic pathway but also cell migration through RAC1 (Ras-related C3 botulinum toxin substrate 1) and vimentin. In fact, RAB7A regulates vimentin phosphorylation at different sites and vimentin assembly, and, in this study, we identified vimentin domains interacting with RAB7A. As several kinases could be responsible for vimentin phosphorylation, we investigated whether modulation of RAB7A expression affects the activity of these kinases. We discovered that RAB7A regulates AKT and PAK1, and we demonstrated that increased vimentin phosphorylation at Ser38 (Serine 38), observed upon RAB7A overexpression, is due to AKT activity. As AKT and PAK1 are key regulators of several cellular events, we investigated if RAB7A could have a role in these processes by modulating AKT and PAK1 activity. We found that RAB7A protein levels affected beta-catenin and caspase 9 expression. We also observed the downregulation of cofilin-1 and decreased matrix metalloproteinase 2 (MMP2) activity upon RAB7A silencing. Altogether these results demonstrate that RAB7A regulates AKT and PAK1 kinases, affecting their downstream effectors and the processes they regulate, suggesting that RAB7A could have a role in a number of cancer hallmarks.
RAB7A是一种小GTP酶,它不仅控制晚期内吞途径,还通过RAC1(Ras相关的C3肉毒杆菌毒素底物1)和波形蛋白来调控细胞迁移。事实上,RAB7A在不同位点调节波形蛋白的磷酸化以及波形蛋白的组装,在本研究中,我们鉴定了与RAB7A相互作用的波形蛋白结构域。由于几种激酶可能负责波形蛋白的磷酸化,我们研究了RAB7A表达的调节是否会影响这些激酶的活性。我们发现RAB7A调节AKT和PAK1,并且我们证明,在RAB7A过表达时观察到的丝氨酸38(Ser38)处波形蛋白磷酸化增加是由于AKT活性所致。由于AKT和PAK1是几种细胞事件的关键调节因子,我们研究了RAB7A是否可能通过调节AKT和PAK1的活性在这些过程中发挥作用。我们发现RAB7A蛋白水平影响β-连环蛋白和半胱天冬酶9的表达。我们还观察到在RAB7A沉默后丝切蛋白-1的下调以及基质金属蛋白酶2(MMP2)活性的降低。总之,这些结果表明RAB7A调节AKT和PAK1激酶,影响它们的下游效应物以及它们所调节的过程,这表明RAB7A可能在许多癌症特征中发挥作用。